Fund Update: JENNISON ASSOCIATES LLC opened a $71.8M position in $GILD stock - Quiver Quantitative
10 hours ago • Google News
Gilead Sciences Inc (GILD)
US$ 106.74-0.91%
Price Chart
Key Statistics
Market Cap
$ 140.79B
P/E Ratio
23.78
Revenue (TTM)
$ 28.74B
Volume
6.97M
52W High
$ 118.28
52W Low
$ 70.17
Dividend Yield
2.76%
Beta
0.31
Technicals
50-Day MA
110.4226
200-Day MA
101.8058
52 Week High
118.2841
52 Week Low
70.167
About GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Employees
17600
Headquarters
Foster City, CA
CEO
Mr. Daniel P. O'Day
Latest News
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Yesterday • Google News
What makes GILD stock price move sharply - Swing Trade Entry Points For Fast Growth - jammulinksnews.com
11 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.15
Percentile: 30.98
Environmental Risk Score
0.53
Percentile: 2
Social Risk Score
12.97
Percentile: 2
Governance Risk Score
7.65
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
GILD
Category Average
2Moderate Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg